Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy

Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer‐related mortality. Despite significant advances made in the treatment of other cancers, current chemotherapies offer little survival benefit in this disease. Pancreaticoduodenectomy offers patients the possibilit...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Bryan W Miller, Jennifer P Morton, Mark Pinese, Grazia Saturno, Nigel B Jamieson, Ewan McGhee, Paul Timpson, Joshua Leach, Lynn McGarry, Emma Shanks, Peter Bailey, David Chang, Karin Oien, Saadia Karim, Amy Au, Colin Steele, Christopher Ross Carter, Colin McKay, Kurt Anderson, Thomas R Jeffry Evans, Richard Marais, Caroline Springer, Andrew Biankin, Janine T Erler, Owen J Sansom
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Springer Nature 2015-06-01
coleção:	EMBO Molecular Medicine
Assuntos:	animal models of cancer collagen cross‐linking lysyl oxidase pancreatic cancer
Acesso em linha:	https://doi.org/10.15252/emmm.201404827
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!